LGALS3 and obesity disorder: These data support the concept that galectin-3 primarily decreases the response of innate and adaptive immunity to overnutrition which leads to adipose tissue inflammation and oxidative stress, thus protecting against the obesity-associated type 2 diabetes [41, 42].